Effects of a Network Program for Preventing Obesity of Patients Taking Antipsychotics or Antidepressants

네트웍 프로그램이 항정신병약물 및 항우울제를 복용하는 환자의 체중과 식이습관에 미치는 영향

  • Kim Soyaja (College of Nursing. Yonsei University) ;
  • Sung Kyung-Mi (Post Doctoral Fellow. School of Nursing. University of Pittsburgh, Researcher, Nursing Policy Research Institute, Yonsei University College of Nursing) ;
  • Hwang Young-Sin (RN, Yonsei University Hospital) ;
  • Kim Sook-Ja (RN, Jeonbook University Hospital)
  • 김소야자 (연세대학교 간호대학, 연세대학교 간호정책연구소) ;
  • 성경미 (연세대학교 간호정책연구소) ;
  • 황영신 (연세대학교 광주 정신병원) ;
  • 김숙자 (전북대학병원 정신과병동)
  • Published : 2005.06.01

Abstract

Purpose: This study was designed to investigate the effects of a network program to prevent obesity and improve dietary habits for patients taking antipsychotics or antidepressants. Method: Thirty-seven patients in two hospitals were assigned to a control group (21 patients) or an intervention group ( 16 patients). The intervention group was evaluated to analyze the effect of the network program for six weeks after the program. Result: There was a difference in the rate of increased body weight between the control group and the intervention group. Notably, the body weight of both groups before the intervention was significantly increased. However, after the intervention the body weight of the intervention group rarely increased, whereas, the body weight of the control group was significantly increased as expected. There was an observed difference in diet between the control group and the intervention group. After the intervention, caloric intake per day of the intervention group decreased. Also, the duration of the meal of the intervention group after the intervention was longer than before. Conclusion: The network program for preventing obesity and improving dietary habits of patients taking antipsychotics or antidepressants was effective. The study shows that a network program can be an important part of a nursing intervention in clinical practice.

Keywords

References

  1. Allebeck, P. (1989). Schizophrenia: A life shortening disease. Schizophr Bull, 15, 81-89
  2. Aronne, L. J. (2001). Epidemiology, Morbidity, and Treatment of overweight and obesity. J Clin Psychiatry, 62(Suppl 23), 13-22
  3. Brownell, K. D. (1985). The Learn Program for weight control. Department of Psychiatry, University of Pensylvania School of Medicine, Philadelphia
  4. Brownell, K. D. (1998). Diet, exercise and behavioural intervention: nonpharmacological approach. Eur J Clin Invest Suppl, 28(2), 19-22 https://doi.org/10.1046/j.1365-2362.1998.0280s2019.x
  5. Fagiolini, A., Frank E., Houck P. R., Mallinger A. G., Swartz H. A., Buysse D. J., Ombao H., & Kupfer D. J. (2002). Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry, 63( 6), 528-533 https://doi.org/10.4088/JCP.v63n0611
  6. Ganguli, R. (1999). Weight gain associated with antipsychotic drugs. J Clin Psychiatry, 60(Suppl 21), 20-24
  7. Goldman, L. S. (1999). Medical illness in patients with schizophrenia. J Clin Psychiatry, 60(Suppl 21), 10-15
  8. Henderson, D. C. (2001). Clozapine: Diabetes Mellitus, Weight gain, and Lipid abnormalites. J Clin Psychiatry, 62(Suppl 23), 39-44
  9. Hughes, J., & Martin, S. (1999). The department of health's project to evaluate weight management services. J Human Nutri. and Dietetics, 12(Suppl. 1), 1-8
  10. Kawachi, I. (1999). Physical and psychological consequences of weight gain. J Clin Psychiatry, 60(Suppl 21), 5-9 https://doi.org/10.4088/JCP.v60n0102
  11. Kim, Y. S. (1995). Etiology and classification of obesity. Kyung-Hee Med, 1(3-4), 244-249
  12. Kwak, S. G., Seo, S. H., & Nam, J. H. (1997). Etiology of death of admitted schizophrenic patients. Ment Heal Res in Korea, 16, 235-248
  13. Lambert T. J. R., Velakoulis D., & Pantelis, C. (2003). Medical comobidity in schizophrenia. Med J Aust, 178(9), 67-70
  14. Larsen D. L., Cannon W., & Towner S. (2003). Longitudinal assessment of a diabetes care management system in an integrated health network. J Manag Care Pharm, 9(6), 552-558
  15. Lee, Y. H., Rhee M. K., Park S. H., Sohn C. H., Chung Y. C., Hong S. K., Lee B. K., Chang P., & Yoon A. R. (1999). The relationship among eating traits, personality characteristics, and other psychopathology in the Korean general population. J Korean Neuropsychiatr Assoc. 38(1), 77-93
  16. Mcintyre R. S., Mancini D. A., & Basile V. S. (2001). Mechanisms of antipsychotic induced weight gain. J Clin Psychiatry, 62(Suppl 23), 23-29
  17. Mundt M. H. (1997). A Model for clinical learning experiences in integrated health care network. J Nurs Educ, 36(7), 309-316
  18. Murray T. A. (1998). A qualitative study of nurses who recently changed from hospital-based practice to home health care nursing. J Contin Educ Nurs, 29(2), 55-60
  19. Ryu, S. H., Jung, I. K., & Kwak, D. I. (1999). The effect of psychotropic drug on serum lipid, lipoprotein, and apolipoprotein. J Korean Neuropsychiatr Assoc, 36(3), 560-569
  20. Sussman, N.(2001). Introduction: Weight gain and glucose regulation during antipsychotic drug treatment. J Clin Psychiatry, 62(Suppl 23), 3-12 https://doi.org/10.4088/JCP.v62n0101
  21. Turunen, H., Tossavainen, K., Jakonen, S., Salomaki, U., & Vertio, H. (1999). Initial results from the European Network of Health Promoting Schools program on development of health education in Finland. J Sch Health., 69(10), 387-391 https://doi.org/10.1111/j.1746-1561.1999.tb06353.x
  22. Wang, S. S., Brownell, K. D., & Wadden, T. A. (2004). The influence of the stigma of obesity on overweight individuals. Intern J of obesity, 28(10), 1333-1337 https://doi.org/10.1038/sj.ijo.0802730
  23. Wirshing, D. A., et al. (1999) Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry, 60(6), 358-363 https://doi.org/10.4088/JCP.v60n0602